Engineered intermonomeric disulfide bonds in the globular domain of newcastle disease virus hemagglutinin-neuraminidase protein: Implications for the mechanism of fusion promotion

Journal of Virology

Volumn 82, Issue 21, 2008, Pages 10386-10396

  Mahon, Paul J ^a,b   Mirza, Anne M ^a   Musich, Thomas A ^a   Iorio, Ronald M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b ASSUMPTION COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; HN PROTEIN; MONOCLONAL ANTIBODY; VIRUS FUSION PROTEIN; DISULFIDE; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL SURFACE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DIMERIZATION; DISULFIDE BOND; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; X RAY CRYSTALLOGRAPHY; ANIMAL; CELL LINE; CHEMICAL STRUCTURE; GENETICS; HAMSTER; METABOLISM; PHYSIOLOGY; SITE DIRECTED MUTAGENESIS; VIRUS ATTACHMENT; VIRUS ENTRY;

NEWCASTLE DISEASE VIRUS; PARAMYXOVIRIDAE;

AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; CRICETINAE; CYSTEINE; DISULFIDES; HN PROTEIN; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; NEWCASTLE DISEASE VIRUS; VIRAL PROTEINS; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

EID: 55249102446     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00581-08     Document Type: Article

References (48)

1. Bousse, T. L., G. Taylor, S. Krishnamurthy, A. Portner, S. K. Samal, and T. Takimoto. 2004. Biological significance of the second sialic acid binding site of Newcastle disease virus hemagglutinin-neuraminidase protein. J. Virol. 78:13351-13355.
2. Choppin, P. W., and A. Scheid. 1980. The role of the viral glycoproteins in adsorption, penetration and pathogenicity of viruses. Rev. Infect. Dis. 2:40-61.
3. Collins, P. L., and G. Mottet. 1991. Homo-oligomerization of the hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3 occurs before the acquisition of correct intramolecular disulfide bonds and mature immunoreactivity. J. Virol. 65:2362-2371.
4. Corey, E. A., and R. M. Iorio. 2007. Mutations in the stalk of the measles virus hemagglutinin protein decrease fusion but do not interfere with virus-specific interaction with the homologous fusion protein. J. Virol. 81:9900-9910.
5. Corey, E. A., A. M. Mirza, E. Levandowsky, and R. M. Iorio. 2003. Fusion deficiency induced by mutations at the dimer interface in the Newcastle disease virus hemagglutinin-neuraminidase is due to a temperature-dependent defect in receptor binding. J. Virol. 77:6913-6922.
6. Crennell, S., T. Takimoto, A. Portner, and G. Taylor. 2000. Crystal structure of the multifunctional paramyxovirus hemagglutinin- neuraminidase. Nat. Struct. Biol. 7:1068-1074.
7. Deng, R., A. M. Mirza, P. J. Mahon, and R. M. Iorio. 1997. Functional chimeric HN glycoproteins derived from Newcastle disease virus and human parainfluenza virus-3. Arch. Virol. Suppl. 13:115-130.
8. Deng, R., Z. Wang, R. L. Glickman, and R. M. Iorio. 1994. Glycosylation within an antigenic site on the HN glycoprotein of Newcastle disease virus interferes with its role in the promotion of membrane fusion. Virology 204:17-26.
9. Deng, R., Z. Wang, P. J. Mahon, M. Marinello, A. M. Mirza, and R. M. Iorio. 1999. Mutations in the NDV HN protein that interfere with its ability to interact with the homologous F protein in the promotion of fusion. Virology 253:43-54.
10. Deng, R., Z. Wang, A. M. Mirza, and R. M. Iorio. 1995. Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike. Virology 209:457-469.
11. DiNapoli, J. M., A. Kotelkin, L. Yang, S. Elankumaran, B. R. Murphy, S. K. Samal, P. L. Collins, and A. Bukreyev. 2007. Newcastle disease virus, a host-range restricted virus, as a vaccine vector for intranasal immunization against emergin pathogens. Proc. Natl. Acad. Sci. USA 23:9788-9793.
12. Elankumaran, S., D. Rockemann, and S. K. Samal. 2006. Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death. J. Virol. 80:7522-7534.
13. Fuerst, T. R., E. G. Niles, F. W. Studier, and B. Moss. 1986. Eucaryotic transient expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83:8122-8126.
14. Gao, Q., M. S. Park, and P. Palese. 2008. Expression of transgenes from Newcastle disease virus with a segmented genome. J. Virol. 82:2692-2698.
15. Gravel, K., and T. G. Morrison. 2003. Interacting domains of the HN and F proteins of Newcastle disease virus. J. Virol. 77:11040-11049.
16. Huang, Z., S. Elankumaran, A. S. Yunus, and S. K. Samal. 2004. A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV. J. Virol. 78:10054-10063.
17. Iorio, R. M., J. B. Borgman, R. L. Glickman, and M. A. Bratt. 1986. Genetic variation within a neutralizing domain on the haemagglutinin- neuraminidase glycoprotein of Newcastle disease virus. J. Gen. Virol. 67:1393-1403.
18. Iorio, R. M., and M. A. Bratt. 1983. Monoclonal antibodies to Newcastle disease virus: delineation of four epitopes on the HN glycoprotein. J. Virol. 48:440-450.
19. Iorio, R. M., G. M. Field, J. M. Sauvron, A. M. Mirza, R. Deng, P. J. Mahon, and J. Langedijk. 2001. Structural and functional relationship between the receptor recognition and neuraminidase activities of the Newcastle disease virus hemagglutinin-neuraminidase protein: receptor recognition is dependent on neuraminidase activity. J. Virol. 75:1918-1927.
20. Iorio, R. M., R. L. Glickman, A. M. Riel, J. P. Sheehan, and M. A. Bratt. 1989. Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: monoclonal antibodies to some sites prevent viral attachment. Virus Res. 13:245-262.
21. Iorio, R. M., R. L. Glickman, and J. P. Sheehan. 1992. Inhibition of fusion by neutralizing monoclonal antibodies to the haemagglutinin- neuraminidase glycoprotein of Newcastle disease virus. J. Gen. Virol. 73:1167-1176.
22. Iorio, R. M., K. A. Lawton, P. M. Nicholson, and M. A. Bratt. 1984. Monoclonal antibodies identify a strain-specific epitope on the HN glycoprotein of Newcastle disease virus strain Australia-Victoria. Virus Res. 1:513-525.
23. Iorio, R. M., R. J. Syddall, R. L. Glickman, A. M. Riel, J. P. Sheehan, and M. A. Bratt. 1989. Identification of amino acid residues important to the neuraminidase activity of the HN glycoprotein of Newcastle disease virus. Virology 173:196-204.
24. Iorio, R. M., R. J. Syddall, J. P. Sheehan, M. A. Bratt, R. L. Glickman, and A. M. Riel. 1991. Neutralization map of the HN glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition. J. Virol. 65:4999-5006.
25. Krishnamurthy, S., T. Takimoto, R. A. Scoggs, and A. Portner. 2006. Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines. J. Virol. 80:5145-5155.
26. Lamb, R. A., and G. D. Parks. 2007. Paramyxoviridae: the viruses and their replication, p. 1449-1496. In D. M. Knipe and P. M. Howley (ed.), Fundamental virology, 5th ed. Wolters Kluwer/Lippincott, The Williams & Wilkins, Philadelphia, PA.
27. Lawrence, M. C., N. A. Borg, V. A. Streltsov, P. A. Pilling, V. C. Epa, J. N. Varghese, J. L. McKimm-Breschkin, and P. M. Colman. 2004. Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III. J. Mol. Biol. 335:1343-1357.
28. Li, J., E. Quinlan, A. Mirza, and R. M. Iorio. 2004. Mutated form of the Newcastle disease virus hemagglutinin-neuraminidase interacts with the homologous fusion protein despite deficiencies in both receptor recognition and fusion promotion. J. Virol. 78:5299-5310.
29. Martinez-Sobrido, L., N. Gitiban, A. Fernandez-Sesma, J. Cros, S. E. Mertz, N. A. Jewell, S. Hammond, E. Flano, R. K. Durbin, A. Garcia-Sastre, and J. E. Durbin. 2006. Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector. J. Virol. 80:1130-1139.
30. McGinnes, L. W., and T. G. Morrison. 2006. Inhibition of receptor binding stabilizes Newcastle disease virus HN and F protein-containing complexes. J. Virol. 80:2894-2903.
31. Melanson, V. R., and R. M. Iorio. 2004. Amino acid substitutions in the F-specific domain in the stalk of the Newcastle disease virus HN protein modulate fusion and interfere with its interaction with the F protein. J. Virol. 78:13053-13061.
32. Melanson, V. R., and R. M. Iorio. 2006. Addition of N-Glycans in the stalk of the Newcastle disease virus HN protein blocks its interaction with the F protein and prevents fusion. J. Virol. 80:623-633.
33. Mirza, A. M., R. Deng, and R. M. Iorio. 1994. Site-directed mutagenesis of a conserved hexapeptide in the paramyxovirus hemagglutinin- neuraminidase glycoprotein: effects on antigenic structure and function. J. Virol. 68:5093-5099.
34. Mirza, A. M., J. P. Sheehan, L. W. Hardy, R. L. Glickman, and R. M. Iorio. 1993. Structure and function of a membrane anchor-less form of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. J. Biol. Chem. 268:21425-21431.
35. Morrison, T. G., and L. J. Ward. 1984. Intracellular processing of the vesicular stomatitis glycoprotein and the Newcastle disease virus hemagglutinin-neuraminidase glycoprotein. Virus. Res. 1:225-239.
36. Ng, D. T. W., R. E. Randall, and R. A. Lamb. 1989. Intracellular maturation and transport of the SV5 type II glycoprotein hemagglutinin- neuraminidase: specific and transient association with GRP78-BiP in the endoplasmic reticulum and extensive internalization from the cell surface. J. Cell Biol. 109:3273-3289.
37. Park, M. S., J. Steel, A. Garcia-Sastre, D. Swayne, and P. Palese. 2006. Engineered viral vaccine construct with dual specificity: avian influenza and Newcastle disease. Proc. Natl. Acad. Sci. USA 103:8203-8208.
38. Porotto. M., M. Fornabaio, G. E. Kellogg, and A. Moscona. 2007. A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism. J. Virol. 81:3216-3228.
39. Scheid, A., and P. W. Choppin. 1974. Identification and biological activities of paramyxovirus glycoproteins: activation of cell fusion, hemolysis and infectivity by proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology 57:475-490.
40. Sheehan, J. P., R. M. Iorio, R. J. Syddall, R. L. Glickman, and M. A. Bratt. 1987. Reducing agent-sensitive dimerization of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus correlates with the presence of cysteine at residue 123. Virology 161:603-606.
41. Takimoto, T., G. L. Taylor, H. C. Connaris, S. J. Crennell, and A. Portner. 2002. Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion. J. Virol. 76:13028- 13033.
42. Tanabayashi, K., and R. W. Compans. 1996. Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion. J. Virol. 70:6112-6118.
43. Thompson, S. D., W. G. Laver, K. G. Murti, and A. Portner. 1988. Isolation of a biologically active soluble form of the hemagglutinin- neuraminidase protein of Sendai virus. J. Virol. 62:4653-4660.
44. Tsurudome, M., M. Kawano, T. Yuasa, N. Tabata, M. Nishio, H. Komada, and Y. Ito. 1995. Identification of regions on the hemagglutinin- neuraminidase protein of parainfluenza virus type 2 important for promoting cell fusion. Virology 213:190-203.
45. Vigil, A., M. S. Park, O. Martinez, M. A. Chua, S. Xioa, J. F. Cros, L. Martinez-Sobrido, S. L. Woo, and A. Garcia-Sastre. 2007. Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus. Cancer Res. 67:8285-8292.
46. Wang, Z., A. M. Mirza, J. Li, P. J. Mahon, and R. M. Iorio. 2004. An oligosaccharide at the C terminus of the F-specific domain in the stalk of the human parainfluenza virus 3 hemagglutinin-neuraminidase modulates fusion. Virus Res. 99:177-185.
47. Yuan, P., T. B. Thompson, B. A. Wurzburg, R. G. Paterson, R. A. Lamb, and T. S. Jardetzky. 2005. Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose. Structure 13:803-815.
48. Zaitsev, V., M. von Itzstein, D. Groves, M. Kiefel, T. Takimoto, A. Portner, and G. Taylor. 2004. Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion. J. Virol. 78:3733-3741.